Cell (company)

Cell is a California-based company.

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
CELL GENESYS INC funding round, April 2009
310,000
April 2009
1 Result
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Research and Markets
February 9, 2021
www.prnewswire.com:443
/PRNewswire/ -- The "Cell Therapy Market by Cell Type, Therapy Type, Therapeutic Area, and End User: Global Opportunity Analysis and Industry Forecast,...
AmerisourceBergen
February 1, 2021
FierceBiotech
Product developments in cell and gene therapy are both among the most groundbreaking and the most complex. Cell and gene therapy product launch success hinges on investment in the right technology and data solutions, and that also means finding the right partner.
Cognate BioServices
January 27, 2021
www.prnewswire.com:443
/PRNewswire/ -- Cognate BioServices, Inc., the premier commercial-ready global CDMO in the Cell and Gene Therapy industry, and Nucleus Biologics, LLC, The Cell...
DarwinHealth
January 12, 2021
www.prnewswire.com:443
/PRNewswire/ -- DarwinHealth, Inc., una empresa de biotecnología y descubrimiento de medicamentos para el cáncer con sede en Nueva York, anuncia la publicación...
DarwinHealth
January 11, 2021
www.prnewswire.com:443
/PRNewswire/ -- DarwinHealth, Inc., a New York-based biotechnology and cancer drug discovery company announces the January 11, 2021 online publication in Cell...
Research and Markets
January 11, 2021
www.prnewswire.com:443
/PRNewswire/ -- The "Cardiovascular Drug Delivery - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to...
Research and Markets
January 8, 2021
www.prnewswire.com:443
/PRNewswire/ -- The "Cell and Gene Therapy Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering....
November 17, 2020
clinicaltrials.gov
BCG Vaccination to Prevent COVID 19 - Full Text View.
Wendy Orent, Undark
November 16, 2020
Smithsonian Magazine
History and science suggest many possible pathways for pandemics, but questions remain about how this one will end
Research and Markets
November 11, 2020
www.prnewswire.com:443
/PRNewswire/ -- The "Cell Therapy - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering....
Press Trust of India
July 6, 2020
@bsindia
The devices have been formed on chips while preserving the orientation and functionality of the cell membrane, according to the results published in two papers
Scott K. Johnson
June 10, 2020
Ars Technica
Efforts spread as many reflect on academia's own problems.
Gail Dutton
June 1, 2020
BioSpace
Cell and gene therapies must scale up on an industrial level if they are to deliver their full potential to patients worldwide, according to speakers at the International Society of Cell Therapy meeting, ISCT Paris 2020 Virtual, May 29.
Kendall Powell
January 22, 2020
Scientific American
Scientific American is the essential guide to the most awe-inspiring advances in science and technology, explaining how they change our understanding of the world and shape our lives.
December 2, 2019
WebWire
GE Healthcare Life Sciences continues to build out its flexible solutions across the cell therapy workflow with the commercial availability of SpinOculation C-Pro Protocol Software. Part of the SepaxTM C-Pro Cell Processing System, the software closes and automates the cell transduction step. When used in combination with the Sepax C-Pro instrument and CT-60.1 single-use kit, the software enables users to choose the volume and cell concentration from initial cell preparation through transdu...
December 1, 2019
SciTechDaily
Over the course of several months, researchers in Israel created Escherichia coli strains that consume CO2 for energy instead of organic compounds. This achievement in synthetic biology highlights the incredible plasticity of bacterial metabolism and could provide the framework for future carbon-neu
Tim Spector
October 10, 2019
phys.org
We choose our food for a variety of reasons, including personal preference, availability, cost and healthiness. But we should also take our gut microbes' preferences into account, a new study published in Cell suggests.
Tia Ghose
September 12, 2019
livescience.com
A 'rogue hybrid' immune cell could play a key role in type 1 diabetes, by acting in two ways in the immune system to recognize and attack pancreatic cells.
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.